Afatinib as first-line treatment in patients with -mutated non-small cell lung cancer in routine clinical practice

by Wolfgang M. Brückl, Martin Reck, Frank Griesinger, Harald Schäfer, Cornelius Kortsik, Tobias Gaska, Justyna Rawluk, Stefan Krüger, Konrad Kokowski, Stephan Budweiser, Joachim H. Ficker, Christopher Hoffmann, Andrea Schüler, Eckart Laack
Published 2021-05-01

Deficiency of Antioxidative Paraoxonase 2 (Pon2) Leads to Increased Number of Phenotypic LT-HSCs and Disturbed Erythropoiesis

by Lisa Spiecker, Ines Witte, Julia Mehlig, Viral Shah, Markus Meyerhöfer, Patricia S. Haehnel, Victoria Petermann, Andrea Schüler, Piyush More, Nina Cabezas-Wallscheid, Sven Horke, Andrea Pautz, Andreas Daiber, Daniel Sasca, Thomas Kindler, Hartmut Kleinert
Published 2021-01-01